Olaparib for BRCA mutant pancreas cancer: Should the POLO trial change clinical practice?

Go Nishikawa, Christopher Booth, Vinay Prasad

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)4087-4088
Number of pages2
JournalCancer
Volume126
Issue number18
DOIs
StatePublished - Sep 15 2020

Keywords

  • POLO
  • germline BRCA
  • olaparib
  • pancreatic cancer
  • platinum-based chemotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this